Central venous catheter colonization and catheter-related bloodstream infection in intensive care unit: comparing standard with silver integrated catheter

2007 ◽  
Vol 24 (Supplement 39) ◽  
pp. 150-151
Author(s):  
N. Hagau ◽  
D. Studnicska ◽  
M. Flonta ◽  
A. Slavcovici ◽  
S. Cocu
2016 ◽  
Vol 29 (6) ◽  
pp. 373
Author(s):  
Jorge Rodrigues ◽  
Andrea Dias ◽  
Guiomar Oliveira ◽  
José Farela Neves

<p><strong>Introduction:</strong> To determine the central-line associated bloodstream infection rate after implementation of central venous catheter-care practice bundles and guidelines and to compare it with the previous central-line associated bloodstream infection rate.<br /><strong>Material and Methods:</strong> A prospective, longitudinal, observational descriptive study with an exploratory component was performed in a Pediatric Intensive Care Unit during five months. The universe was composed of every child admitted to Pediatric Intensive Care Unit who inserted a central venous catheter. A comparative study with historical controls was performed to evaluate the result of the intervention (group 1 <em>versus</em> group 2).<br /><strong>Results:</strong> Seventy five children were included, with a median age of 23 months: 22 (29.3%) newborns; 28 (37.3%) with recent surgery and 32 (43.8%) with underlying illness. A total of 105 central venous catheter were inserted, the majority a single central venous catheter (69.3%), with a mean duration of 6.8 ± 6.7 days. The most common type of central venous catheter was the short-term, non-tunneled central venous catheter (45.7%), while the subclavian and brachial flexure veins were the most frequent insertion sites (both 25.7%). There were no cases of central-line associated bloodstream infection reported during this study. Comparing with historical controls (group 1), both groups were similar regarding age, gender, department of origin and place of central venous catheter insertion. In the current study (group 2), the median length of stay was higher, while the mean duration of central venous catheter (excluding peripherally inserted central line) was similar in both groups. There were no statistical differences regarding central venous catheter caliber and number of lumens. Fewer children admitted to Pediatric Intensive Care Unit had central venous catheter inserted in group 2, with no significant difference between single or multiple central venous catheter.<br /><strong>Discussion:</strong> After multidimensional strategy implementation there was no reported central-line associated bloodstream infection<br /><strong>Conclusions:</strong> Efforts must be made to preserve the same degree of multidimensional prevention, in order to confirm the effective reduction of the central-line associated bloodstream infection rate and to allow its maintenance.</p>


Author(s):  
Mohammad Ali Abu Sa'aleek

The use of antimicrobial central catheter is common in clinical practice to prevent catheter colonization, therefore preventing catheter-related blood stream infection (CRBSI). This paper aims to evaluate evidence from the literature in order to illustrate the effectiveness of one of the most common antimicrobial central catheters, chlorhexidine/silver sulfadiazine central venous catheter, in the prevention of bacterial colonization and CRBSI. Several studies have been selected including randomized control trails (RCTs), meta-analysis and systematic review. The seven RCTs included a total number of 2346 catheters. The patients were either assigned to an intervention group (silver-impregnated central venues catheter) or a control group (standard catheter). These studies were conducted in the USA, Europe, Australia and Brazil from 2004 until 2012. The results revealed that there was a discrepancy in the effectiveness of using silver-impregnated central venous catheter in prevention of catheter colonization and catheter- related bloodstream infection. More recent randomized studies are needed to solve this discrepancy, with a focus on following of infection control measures as the golden standard to prevent colonization and reduction of CRBSI.


2016 ◽  
Vol 12_2016 ◽  
pp. 114-120
Author(s):  
Lyubasovskaya L.A. Lyubasovskaya ◽  
Priputnevich T.V. Priputnevich ◽  
Nikitina I.V. Nikitina ◽  
Kornienko M.A. Kornienko ◽  
Rodchenko Yu.V. Rodchenko ◽  
...  

2005 ◽  
Vol 26 (8) ◽  
pp. 715-719 ◽  
Author(s):  
Mary-Louise McLaws ◽  
Geoffrey Berry

AbstractObjective:To determine whether the conventional rate for central venous catheter (CVC)-associated bloodstream infection (BSI) accurately reflects risk for patients exposed for a variety of in situ periods.Patients and Methods:Intensive care unit patients (n = 1,375) were monitored for 7,467 CVC-days. They were monitored until catheter removal, until diagnosis of CVC-associated BSI, or for 24 hours after discharge.Results:The BSI rate was 3.7 per 1,000 CVC-days. Ninety-three percent of these patients had CVCs in situ for 1-15 days. These patients were exposed to 59.7% of all CVC-days; the remaining 7% were exposed to 40.3% of all CVC-days. BSI rates stratified by exposure periods of 1-5 and 6-15 days were 2.1 and 4.5 per 1,000 CVC-days, respectively. The rates for 16-30 and 31-320 days were 10.2 and 2.1 per 1,000 CVC-days, respectively. The probability of BSI with a CVC in situ was 6 in 100 by day 15, 14 in 100 by day 25, 21 in 100 by day 30, and 53 in 100 by day 320.Conclusion:The conventional aggregated rate better reflects the risk for the majority of patients rather than for patients exposed to the majority of CVC-days. It does not reflect the true probability of risk for all exposures, especially beyond 30 days. CVCs in situ from 1 to 15 days had less risk of BSI than CVCs in situ more than 15 days, which may explain why scheduled CVC replacement at days 5 to 7 has not been found beneficial.


Sign in / Sign up

Export Citation Format

Share Document